The effectiveness of switching from an originator biological agent to its biosimilar, or vice versa, for ankylosing spondylitis in real clinical practice von K. V. Sakharova, M. V. Podryadnova, Sh. F. Erdes

Volltext

THE SEVERE COURSE OF DRUG THERAPY-RESISTANT ANKYLOSING SPONDYLITIS von Rumyantseva, D. G., Podryadnova, M. V., Rumyantseva, O. A., Urumova, M. M., Erdes, Sh

Volltext

CORRELATION BETWEEN CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS AND WORK CAPACITY AND PRODUCTIVITY von Podryadnova, M. V., Balabanova, R. M., Urumova, M. M., Erdes, Sh. F.

Volltext

COXITIS IN ANKYLOSING SPONDYLITIS: COMPARISON OF CLINICAL MANIFESTATIONS WITH ULTRASOUND STUDY DATA von Podryadnova, M. V., Balabanova, R. M., Urumova, M. M., Erdes, Sh. F.

Volltext

THERAPEUTIC EXERCISE FOR PATIENTS WITH ANKYLOSING SPONDYLITIS: RECOMMENDATIONS AND REALITY von Dubinina, T. V., Podryadnova, M. V., Krasnenko, S. O., Erdes, Sh. F.

Volltext

Significance of asymptomatic hyperuricemia in ankylosing spondylitis von R. M. Balabanova, E. V. Ilyinykh, M. V. Podryadnova, S. I. Glukhova, M. M. Urumova

Volltext

Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis von Sh. F. Erdes, M. V. Podryadnova

Volltext

Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis von Rimma Mikhailovna Balabanova, M. V. Podryadnova

Volltext

The effectiveness of switching from an originator biological agent to its biosimilar, or vice versa, for ankylosing spondylitis in real clinical practice von Sakharova, K. V., Podryadnova, M. V., Erdes, Sh. F.

Volltext

Significance of asymptomatic hyperuricemia in ankylosing spondylitis von Balabanova, R. M., Ilyinykh, E. V., Podryadnova, M. V., Glukhova, S. I., Urumova, M. M.

Volltext

15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) von N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

Volltext

15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) von N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

Volltext

Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis von Erdes, Sh. F., Podryadnova, M. V.

Volltext

Delayed poor response during effective tocilizumab treatment for refractory adult-onset Still's disease von Muravyev, Yuri Vladimirovich, Alekseyeva, A V, Podryadnova, M V

Volltext

Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis von Balabanova, Rimma Mikhailovna, Podryadnova, M. V.

Volltext

Delayed poor response during effective tocilizumab treatment for refractory adult-onset Still's disease von Yuri Vladimirovich Muravyev, A V Alekseyeva, M V Podryadnova

Volltext

AB0780 Correlation Between Disease Duration and Long Term Loss of Work Disability in Patients with Ankylosing Spondylitis von Podryadnova, M., Balabanova, R.M., Dubinina, T.V., Urumova, M.M., Erdes, S.F.

Volltext

AB0779 Should Ultrasound Coxitis Criteria in Ankylosing Spondylitis be Reviewed? von Podryadnova, M., Urumova, M.M., Dubinina, T.V., Balabanova, R.M., Erdes, S.F.

Volltext